Home Cart Sign in  
Chemical Structure| 210644-62-5 Chemical Structure| 210644-62-5

Structure of (Z)-Orantinib
CAS No.: 210644-62-5

Chemical Structure| 210644-62-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SU6668 is a cell-permeable indolinone compound that acts as a potent ATP-competitive inhibitor against RTKs (receptor tyrosine kinases) Kit, PDGFRβ, VEGFR2 (Flk-1/KDR), FGFR1 activity in vitro (IC50 = 0.01, 0.1, 3.9, and 3.8 µM, respectively) and PDGF/VEGF/bFGF-mediated angiogenesis and tumor development. Although initially characterized as an RTK inhibitor, SU6668 is now also known to target ser/thr kinases Aurora A, Aurora B, TBK1 (NAK/T2K), and AMPK (IC50 = 0.85, 0.047, 1.4, and 1.8 µM, respectively), as well as non-receptor TKs Lyn and Yes (IC50 = 4.3 and 5.8 µM, respectively).

Synonyms: SU6668; (Z)-TSU-68; (Z)-SU6668

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of (Z)-Orantinib

CAS No. :210644-62-5
Formula : C18H18N2O3
M.W : 310.35
SMILES Code : O=C(O)CCC1=C(C)NC(/C=C2C(NC3=C\2C=CC=C3)=O)=C1C
Synonyms :
SU6668; (Z)-TSU-68; (Z)-SU6668
MDL No. :MFCD09743433
InChI Key :NHFDRBXTEDBWCZ-ZROIWOOFSA-N
Pubchem ID :5329099

Safety of (Z)-Orantinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335-H413
Precautionary Statements:P261-P305+P351+P338

Related Pathways of (Z)-Orantinib

epigenetics
DNA
RTK
PI3K-AKT
pyroptosis
TLR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00784290 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - Japan ... More >> Chiba University Hospital Inohana Chuo-ku Chiba, Chiba, Japan, 260-8670 Less <<
NCT00024063 Breast Cancer ... More >> Colorectal Cancer Gastric Cancer Kidney Cancer Lung Cancer Multiple Myeloma and Plasma Cell Neoplasm Pancreatic Cancer Prostate Cancer Less << Phase 1 Unknown - -
NCT01465464 Hepatocellular Carcinoma Phase 3 Terminated - Japan ... More >> Local Institution Osaka-sayama, Osaka, Japan, 589-8511 Local Institution Chuo-ku, Tokyo, Japan, 104-0045 Local Institution Chiba, Japan, 260-8677 Korea, Republic of Local Institution Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Local Institution JongNo-Gu, Seoul, Korea, Republic of, 110-744 Taiwan Local Institution Zhongzheng Dist., Taipei, Taiwan, 100 Less <<
NCT00024206 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.22mL

0.64mL

0.32mL

16.11mL

3.22mL

1.61mL

32.22mL

6.44mL

3.22mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories